Search
Frequency Therapeutics Closes $62MM Series C Financing
- Jul 24, 2019
- 1 min read
Congratulations to Frequency Therapeutics!
They have announced the close of their $62mm Series C financing to expand research of their innovative drug candidate for hearing restoration and its potential for other degenerative diseases using their first-in-class Progenitor Cell Activation platform.
https://www.linkedin.com/feed/update/urn:li:activity:6559391537099264001
Comments